The Discrepancy in Radiologists' Practice of Intravenous Contrast Imaging Studies Among Chronic Kidney Disease Patients

February 6, 2023 updated by: Mahmoud Hamada imam, Benha University
  • There is a discrepancy between protocols used for intravenous imaging for chronic kidney disease including hemodialysis patients among different hospitals and even, among radiologists same selves.
  • This questionnaire based study aims to quantify that discrepancy and describe the variables associated with the discrepancy.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

  • There is a discrepancy between protocols used for intravenous imaging for chronic kidney disease including hemodialysis patients among different hospitals and even, among radiologists same selves.
  • This questionnaire-based study aims to quantify that discrepancy and describe the variables associated with the discrepancy.

Study Type

Observational

Enrollment (Actual)

266

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Qalubia
      • Banhā, Qalubia, Egypt, 13422
        • benha faculty of medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

24 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Radiology physicians

Description

Inclusion Criteria:

  • Practicing radiologist

Exclusion Criteria:

  • retired radiologist

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
active arm
participants responding to the questionnaire emailed.
A questionnaire form is emailed to radiologists to get their response of their practice with hemodialysis and chronic kidney disease patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
time from IV contrast study and next dialysis session
Time Frame: 1 day
time from IV contrast study and next dialysis session
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 12, 2021

Primary Completion (Actual)

September 19, 2021

Study Completion (Actual)

November 20, 2021

Study Registration Dates

First Submitted

August 19, 2022

First Submitted That Met QC Criteria

February 6, 2023

First Posted (Actual)

February 15, 2023

Study Record Updates

Last Update Posted (Actual)

February 15, 2023

Last Update Submitted That Met QC Criteria

February 6, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

For privacy reasons of participants

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Kidney Diseases

Clinical Trials on Questionnare

3
Subscribe